Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
PERTZYE® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
- generic_name
- pancrelipase
- product_names
- pancrelipase
- ndc
- 59767-008, 59767-016, 59767-004, 59767-024, 59767-008-01, 59767-008-02, 59767-008-99, 59767-008-00, 59767-004-01, 59767-004-99, 59767-016-01, 59767-016-02, 59767-016-99, 59767-016-00, 59767-024-01, 59767-024-02, 59767-024-99, 59767-024-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en